Q2 2024 Holdings
Filed 2024-08-14 | 22 holdings | $107.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Genedx Holdings Corp(WGS) | COM CL A | 81663L200 | $28.9M | 1,105,768 | 27.0% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $24.3M | 700,450 | 22.7% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $11.0M | 1,488,131 | 10.3% |
| Springworks Therapeutics Inc | COM | 85205L107 | $8.8M | 233,200 | 8.2% |
| Biohaven LTD(BHVN)Call | CALL | G1110E907 | $4.0M | 115,000 | 3.7% |
| Quidelortho Corp(QDEL) | COM | 219798105 | $3.9M | 118,291 | 3.7% |
| Eyepoint Pharmaceuticals IncCall | CALL | 30233G909 | $3.8M | 438,100 | 3.6% |
| Forian Inc(FORA) | COM | 34630N106 | $3.6M | 1,356,107 | 3.4% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $3.3M | 535,558 | 3.1% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $2.3M | 225,000 | 2.2% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $2.0M | 231,857 | 1.9% |
| Ardelyx IncCall | CALL | 039697907 | $1.9M | 259,600 | 1.8% |
| Myriad Genetics IncCall | CALL | 62855J904 | $1.8M | 74,500 | 1.7% |
| Palantir Technologies IncCall | CALL | 69608A908 | $1.8M | 70,000 | 1.7% |
| Cava Group Inc(CAVA) | COM | 148929102 | $1.7M | 18,600 | 1.6% |
| Myriad Genetics Inc(MYGN) | COM | 62855J104 | $1.5M | 60,000 | 1.4% |
| Springworks Therapeutics IncCall | CALL | 85205L907 | $670.5K | 17,800 | 0.6% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $579.7K | 423,138 | 0.5% |
| Biogen Inc(BIIB) | COM | 09062X103 | $559.2K | 2,412 | 0.5% |
| Walgreens Boots Alliance Inc(WBA) | COM | 931427108 | $332.6K | 27,500 | 0.3% |
| Agenus Inc(AGEN) | COM NEW | 00847G804 | $293.1K | 17,500 | 0.3% |
| Biodesix Inc | COM | 09075X108 | $44.2K | 28,916 | 0.0% |